Clinical Trials
5 trialsNCT02669771 2024-11-21
Long-Term Specified Drug Use-Results Survey for Xtandi Capsule
Astellas Pharma Inc
Completed
NCT02207504 2022-01-06
Crizotinib in Combination With Enzalutamide in Metastatic Castration-resistant Prostate Cancer
Dana-Farber Cancer Institute
Phase 1 Completed
NCT02346578 2021-09-16
Comparative Study of Alternative Antiandrogen (AA) Therapy and Early Initiating of Enzalutamide for Castration-resistant Prostate Cancer (CRPC) After Combined Androgen Blockade (CAB) Therapy.
Osaka City University
Phase 2 Completed
NCT03305224 2021-09-09
CORE-OCU
Osaka City University
Phase 2 Unknown
NCT02429193 2020-01-13
BARRIER-P
University Health Network, Toronto
Phase 2 Completed